ALX Oncology Holdings, Inc. (ALXO)
1.19
-0.07
(-5.56%)
USD |
NASDAQ |
Dec 30, 16:00
1.19
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings EPS Diluted (Quarterly): -0.4133 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Erasca, Inc. | -0.1079 |
| Immuneering Corp. | -0.3772 |
| CEL-SCI Corp. | -0.7611 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.14M |
| Total Expenses (Quarterly) | 22.14M |
| Enterprise Value | 19.50M |
| Earnings Yield | -170.4% |
| Normalized Earnings Yield | -166.88 |